RGLS - Regulus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

RGLS is currently covered by 3 analysts with an average price target of $16.04. This is a potential upside of $13.48 (526.56%) from yesterday's end of day stock price of $2.56.

Regulus Therapeutics's activity chart (see below) currently has 21 price targets and 29 ratings on display. The stock rating distribution of RGLS is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.94% with an average time for these price targets to be met of 89.5 days.

Highest price target for RGLS is $12, Lowest price target is $3, average price target is $16.04.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 25-Mar-2024. First documented stock forecast 22-Oct-2014.

Best performing analysts who are covering RGLS - Regulus Therapeutics:

Madhu Kumar Liana Moussatos Jim Birchenough Whitney Ijem Raghuram Selvaraju Matthew Luchini

Currently out of the existing stock ratings of RGLS, 4 are a BUY (80%), 1 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$6.33 (237.08%)

9

24 days ago

1/4 (25%)

$6.18 (219.15%)

255

Hold

3

$0.33 (12.36%)

1 months 5 days ago

1/4 (25%)

$0.57 (23.46%)

139

Buy

12

$10.63 (775.91%)

6 months 28 days ago

0/1 (0%)

$10.71 (830.23%)

Hold

4.2

$1.53 (57.30%)

48

2 years 2 months 28 days ago

2/3 (66.67%)

$1.96 (87.50%)

63

Hold

30

$27.33 (1023.60%)

5 years 8 months 4 days ago

3/4 (75%)

$-1.56 (-4.94%)

80

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RGLS (Regulus Therapeutics) average time for price targets to be met?

On average it took 89.5 days on average for the stock forecasts to be realized with a an average price target met ratio 31.94

Which analyst has the current highest performing score on RGLS (Regulus Therapeutics) with a proven track record?

MADHU KUMAR

Which analyst has the current lower performing score on RGLS (Regulus Therapeutics) with a proven track record?

MATTHEW LUCHINI

Which analyst has the most public recommendations on RGLS (Regulus Therapeutics)?

Madhu Kumar works at GOLDMAN SACHS and has 8 price targets and 5 ratings on RGLS

Which analyst is the currently most bullish on RGLS (Regulus Therapeutics)?

Matthew Luchini with highest potential upside - $161.73

Which analyst is the currently most reserved on RGLS (Regulus Therapeutics)?

Jim Birchenough with lowest potential downside - $0.33

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?